Showing results (71-80 of 496) with videos related to
Sort By:
Pageof 50
Brain Research|June 12, 1989
Regional distribution of [3H]MK-801 binding sites in the human brainJ Kornhuber, F Mack-Burkhardt, P RiedererJournal of Molecular Medicine (Berlin, Germany)|July 1, 1996
The role of neurotransporters in excitotoxicity, neuronal cell death, and other neurodegenerative processesK P Lesch, A Heils, P RiedererJournal of the Royal Society of Medicine|September 1, 1981
Tranylcypromine isomers and Parkinson's disease: new aspects of an old drugG P Reynolds, P Riederer, M SandlerJournal of Neural Transmission. Supplementum|January 1, 1994
Is selegiline neuroprotective in Parkinson's disease?M Gerlach, M B Youdim, P RiedererJournal of Neural Transmission. Supplementum|January 1, 1990
Oxidative stress: a role in the pathogenesis of Parkinson's diseaseM E Götz, A Freyberger, P RiedererActa Neurologica Scandinavica. Supplementum|January 1, 1989
Is Parkinson's disease a progressive siderosis of substantia nigra resulting in iron and melanin induced neurodegeneration?M B Youdim, D Ben-Shachar, P RiedererAdvances in Neurology|January 1, 1993
Recent advances in pharmacological therapy of Parkinson's diseaseP Riederer, K W Lange, M B YoudimJournal of Neural Transmission (Vienna, Austria : 1996)|July 12, 2002
Different modes of action of catecholamine-O-methyltransferase inhibitors entacapone and tolcapone on adenylyl cyclase activity in vitroM Gerlach, W Ukai, H Ozawa, et al.Parkinsonism & Related Disorders|September 10, 2002
Degeneration of neuronal cells due to oxidative stress--microglial contributionE Koutsilieri, C Scheller, F Tribl, et al.Journal of Neural Transmission. Supplementum|January 1, 1997
Neurochemical abnormalities in Alzheimer's disease and Parkinson's disease--a comparative reviewW Gsell, I Strein, U Krause, et al.Pageof 50